Wehbe M - Search Results

1

Concomitant Chemoradiation Therapy with Gold Nanoparticles and Platinum Drugs Co-Encapsulated in Liposomes.

Charest G, Tippayamontri T, Shi M, Wehbe M, Anantha M, Bally M, Sanche L. Charest G, et al. Among authors: wehbe m. Int J Mol Sci. 2020 Jul 9;21(14):4848. doi: 10.3390/ijms21144848. Int J Mol Sci. 2020. PMID: 32659905 Free PMC article.

2

Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent.

Wehbe M, Anantha M, Shi M, Leung AW, Dragowska WH, Sanche L, Bally MB. Wehbe M, et al. Int J Nanomedicine. 2017 May 31;12:4129-4146. doi: 10.2147/IJN.S137347. eCollection 2017. Int J Nanomedicine. 2017. PMID: 28615941 Free PMC article.

3

Copper (II) complexes of bidentate ligands exhibit potent anti-cancer activity regardless of platinum sensitivity status.

Wehbe M, Lo C, Leung AWY, Dragowska WH, Ryan GM, Bally MB. Wehbe M, et al. Invest New Drugs. 2017 Dec;35(6):682-690. doi: 10.1007/s10637-017-0488-2. Epub 2017 Jul 21. Invest New Drugs. 2017. PMID: 28733701 Free PMC article.

4

Liposomal formulations of carboplatin injected by convection-enhanced delivery increases the median survival time of F98 glioma bearing rats.

Shi M, Anantha M, Wehbe M, Bally MB, Fortin D, Roy LO, Charest G, Richer M, Paquette B, Sanche L. Shi M, et al. Among authors: wehbe m. J Nanobiotechnology. 2018 Oct 5;16(1):77. doi: 10.1186/s12951-018-0404-8. J Nanobiotechnology. 2018. PMID: 30290821 Free PMC article.

5

Characterization of a liposomal copper(II)-quercetin formulation suitable for parenteral use.

Chen KTJ, Anantha M, Leung AWY, Kulkarni JA, Militao GGC, Wehbe M, Sutherland B, Cullis PR, Bally MB. Chen KTJ, et al. Among authors: wehbe m. Drug Deliv Transl Res. 2020 Feb;10(1):202-215. doi: 10.1007/s13346-019-00674-7. Drug Deliv Transl Res. 2020. PMID: 31482519 Free PMC article.

6

Irinophore C™, a lipid nanoparticle formulation of irinotecan, abrogates the gastrointestinal effects of irinotecan in a rat model of clinical toxicities.

Waterhouse DN, Sutherland BW, Santos ND, Masin D, Osooly M, Strutt D, Ostlund C, Anantha M, Harasym N, Manisali I, Wehbe M, Bally MB, Webb MS. Waterhouse DN, et al. Among authors: wehbe m. Invest New Drugs. 2014 Dec;32(6):1071-82. doi: 10.1007/s10637-014-0138-x. Epub 2014 Jul 27. Invest New Drugs. 2014. PMID: 25064374 Free PMC article.

7

Nanoscale Reaction Vessels Designed for Synthesis of Copper-Drug Complexes Suitable for Preclinical Development.

Wehbe M, Anantha M, Backstrom I, Leung A, Chen K, Malhotra A, Edwards K, Bally MB. Wehbe M, et al. PLoS One. 2016 Apr 7;11(4):e0153416. doi: 10.1371/journal.pone.0153416. eCollection 2016. PLoS One. 2016. PMID: 27055237 Free PMC article.

8

Copper-CX-5461: A novel liposomal formulation for a small molecule rRNA synthesis inhibitor.

Leung AWY, Anantha M, Dragowska WH, Wehbe M, Bally MB. Leung AWY, et al. Among authors: wehbe m. J Control Release. 2018 Sep 28;286:1-9. doi: 10.1016/j.jconrel.2018.07.025. Epub 2018 Jul 18. J Control Release. 2018. PMID: 30016731 Free article.

9

PRCosomes: pretty reactive complexes formed in liposomes.

Wehbe M, Chernov L, Chen K, Bally MB. Wehbe M, et al. J Drug Target. 2016 Nov;24(9):787-796. doi: 10.1080/1061186X.2016.1186169. Epub 2016 May 22. J Drug Target. 2016. PMID: 27145072 Review.

10

A Perspective - can copper complexes be developed as a novel class of therapeutics?

Wehbe M, Leung AWY, Abrams MJ, Orvig C, Bally MB. Wehbe M, et al. Dalton Trans. 2017 Aug 22;46(33):10758-10773. doi: 10.1039/c7dt01955f. Dalton Trans. 2017. PMID: 28702645 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

154 results

Search Page

Filters